Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Field
-
local communities and with parents. Understanding of the promotoras model of leadership. Fluent communication in both English and Spanish. Equipment Use of personal computer and proficiency in software
-
biology, endocrine disruption, and toxicological mechanisms. Experience with laboratory animal models and histology is advantageous but not required. Responsibilities and qualifications You will support
-
research. The Postdoctoral Scholar – Pharmacometrics in the PhASR will support data collection, quality control of data, data analysis, modeling, simulation and PK/PD study design for human clinical trials
-
. This virulence gene has been captured independently by two different Starship transposons, Sanctuary and Horizon. We seek to understand the mechanistic basis of Starship mediated HGT using these global wheat
-
focus on charge injection, ion transfer, and structural dynamics in realistic and model systems for battery materials. The position will span experimental efforts at large scale X-ray facilities, handling
-
tendon models ("tendon-on-chip"), this will provide a powerful system to investigate the complex mechanobiology of tendons. Particular focus will be given to neurotendinous crosstalk and its
-
in different brain models (tree shrew, macaque, human neurotypical, schizophrenia patients) and levels of analyses (local- and large-scale circuits). This is a unique opportunity to learn about team
-
. Responsibilities Research Develop mathematical models of topologically complex membrane structures using continuum or statistical mechanics. Implement computational models of these structures using methods such as
-
-atomic potentials (e.g. pro-fit, MLIP-3). Knowledge of meso-scale models such as cluster dynamics (e.g. Xolotl, Centipede), object-kinetic Monte Carlo or similar. Proven commitment to proactively keeping
-
the proportion of individuals within different ethnic groups classified as high risk. - Develop multistate survival models (MSM) to estimate transition parameters between cancer progression states across risk